Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +45.24%
#3 ADO Protocol ADO Protocol +38.82%
#4 Prom Prom +33.99%
#5 Pons Pons +33.37%
#6 StonkBroker StonkBroker +30.74%
#7 Collector Crypt Collector Crypt +28.58%
#8 TENDIES TENDIES +26.49%
#9 龙虾 (Lobster) 龙虾 (Lobster) +21.88%
#10 Cysic Cysic +20.12%
Coin of the day
GEKKO GEKKO
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Kedudukan dalam Saham #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Harga Saham
$61.73
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.01B
Perubahan (1 hari)
-1.02%
Perubahan (1 tahun)
5.10%
Negara
DK
Perdagangan Gubra A/S (GUBRA)

Kategori

Healthcare
Hasil untuk Gubra A/S (GUBRA)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Gubra A/S, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Gubra A/S dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH